RxDoctor Payments Data

Landon House, PA

Medical · Saint Louis, MONPI 1235767872

Payments from drug & device makers

$666in general payments, 2019–2025

Across 35 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$100
  • AstraZeneca$95
  • Mylan Specialty L.p.$73
  • Edwards Lifesciences$72
  • Esperion Therapeutics, Inc.$41
  • Exact Sciences$40
  • plus $245 from 12 others

What the payments were for

  • Food & beverage$666100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$666 in reported general payments places this provider in the 50th percentile of 198 medical providers in Missouri.

See all medical providers in Missouri

Medicare billing

Part B allowed, 2024
$26,153
Medicare patients
125
Services billed
312

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban60$51,838
Trelegy ElliptaFluticasone/Umeclidin/Vilanter32$25,665
MounjaroTirzepatide12$13,767
JardianceEmpagliflozin12$13,036
Breo ElliptaFluticasone/Vilanterol14$6,458
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,299
Wixela InhubFluticasone Propion/Salmeterol28$4,450
Venlafaxine Hcl ErVenlafaxine Hcl19$3,076
Fluticasone-SalmeterolFluticasone Propion/Salmeterol16$2,907
Albuterol Sulfate HfaAlbuterol Sulfate119$2,052
Atorvastatin Calcium141$1,267
Losartan Potassium158$1,004
Gabapentin69$937
Levothyroxine Sodium56$758
Duloxetine Hcl35$741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat$19$18,33423 claims
Lilly USA, LLCMounjaro$100$13,76712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 198 medical providers in Missouri.

Other medical in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →